AstraZeneca India has announced a collaboration with Alveofit, a SaaS-IoT enabled respiratory healthcare platform, to provide IoT-enabled handheld spirometers in hospitals across the country.
This collaboration wishes and commits to incorporating the most recent technological advances in diagnosing and managing lung disorders and associated noncommunicable diseases such as asthma, pulmonary fibrosis, and COPD.
AstraZeneca will provide Alveofit IoT-enabled handheld spirometers to clinics and last mile hospitals as part of this collaboration to enable point of care spirometry for optimised management of various lung-associated noncommunicable diseases, which will aid in tracking patients remotely and even conducting telespirometry with comprehensive care management solutions.
AstraZeneca’s A.Catalyst Network embodies the company’s commitment to using science to improve health for as many people, in as many countries, and in as many ways as possible.
AstraZeneca has installed spirometers in selected hospitals across the country as part of its collaboration with Alveofit. In cities such as Lucknow, Chennai, Nagpur, Delhi, Ahmedabad, and Kolkata, this includes ESIC hospitals for industrial employees, Command and Military Hospitals, General Hospitals, and last mile clinics. In a pilot project conducted prior to the launch of this initiative, 2800+ patients were tested, and 35-40% were diagnosed with lung issues ranging from 10-12 years old to 85-90 years old.
AstraZeneca has been developing new methods to assist people in managing their own health. Insights from patients and caregivers from various communities have assisted the company in developing new practises and technologies that enable people to take an active role in their own health by utilising tools such as digital sensors, integrated apps, connected devices, and artificial intelligence.
